a-366,833 a-366,833 a-366,833 is a drug developed by abbott, which acts as an agonist at neural nicotinic acetylcholine receptors selective for the α4β2 subtype, and has been researched for use as an analgesic, although it has not passed clinical trials. its structure has a nicotinonitrile (3-cyanopyridine) core bound through c5 to the n6 of (1r,5s)-3,6-diazabicycloheptane. a-366,833identifiers iupac name 5-hept-6-yl]pyridine-3-carbonitrile cas number370882-41-0 ypubchem cid9834234chemspider8009955 yunii6xrk9htj6mchemblchembl239931 ychemical and physical dataformulac11h12n4molar mass200.239 g·mol−13d model (jsmol)interactive imagemelting point101.4–102.9 °c (214.5–217.2 °f) smiles n#cc1=cn=cc(n23()cnc3()c2)=c1 inchi inchi=1s/c11h12n4/c12-2-8-1-10(5-13-3-8)15-7-9-4-14-6-11(9)15/h1,3,5,9,11,14h,4,6-7h2/t9-,11-/m1/s1 nkey:gpxawldgwsblkm-mwlchtkssa-n n ny (what is this?) (verify)